Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Akzo Nobel

This page shows the latest Akzo Nobel news and features for those working in and with pharma, biotech and healthcare.

Pharma news in brief

Akzo to spin off pharma unit. Dutch chemicals and drug group, Akzo Nobel has announced it plans to spin off its pharmaceutical business after full year net profits for 2005 rose ... said Akzo chief executive Hans Wijers.

Latest news

  • EMEA seeks SSRI warning

    Other medicines covered by the EMEA review included other Lilly products Cymbalta and Strattera, Lundbeck's Celexa and Lexapro, Pfizer's Zoloft, Wyeth's Effexor and Akzo Nobel's Remeron.

  • Xceleron and Organon sign microdose study agreement

    UK-based contract research organisation Xceleron has revealed a collaboration with Organon, the human healthcare business unit of Netherlands-based Akzo Nobel, on a three-compound human microdose study focusing on

  • Schering-Plough completes Organon BioSciences acquisition

    The US company paid approximately EUR 11bn in cash for the company, which used to be a subsidiary of Dutch chemicals giant, Akzo Nobel.

  • Schering-Plough sales double on statins

    Organon acquisition. S-P is in the middle of acquiring Akzo Nobel's Organon unit, which is the second-largest EU manufacturer of contraceptive pills, in order to diversify away from ... In March 2007, S-P announced it was going to purchase Akzo Nobel's

  • Organon and MRC sign up for antibody development programme

    The pharmaceutical unit of Dutch chemicals giant Akzo Nobel, Organon, has signed a collaborative agreement with MRC Technology in the UK to develop a humanised antibody for the treatment of certain

More from news
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...

Quick links